4Accepted Sep 11, 5:44 PM ET
AtaiBeckley (ATAI) Director Robert Hershberg Disposes 741,089 Shares
Accepted (ET)
5:44 PM
Sep 11, 2026
Filed
Sep 11, 2026
Documents
1
Size
14.8 KB
Summary
AtaiBeckley (ATAI) Director Robert Hershberg Disposes 741,089 Shares
What Happened
Robert Hershberg, a director of AtaiBeckley Inc. (ATAI), recorded dispositions of derivative securities totaling 741,089 shares on September 11, 2026. These were not open-market sales but dispositions to the issuer in connection with the merger of AtaiBeckley into a subsidiary of Eli Lilly. Outstanding stock options were cancelled at the merger effective time and converted into a cash amount (based on the option strike and a $6.75 reference price) plus one contingent value right (CVR) per share (each CVR may pay up to $2.50 if certain milestones are met). The filing lists the transactions as derivative dispositions (code D); no per-share cash amounts are reported in the Form 4.
Key Details
- Transaction date: 2026-09-11 (effective with the Merger described in the filing).
- Dispositions reported (derivative): 48,858; 404,869; 62,394; 103,000; 121,968 — total 741,089 shares.
- Price / proceeds: Not reported on the Form 4 (listed as N/A); cash consideration was determined under the Merger agreement formula (see footnote).
- Shares owned after transaction: Not reported in this filing.
- Footnotes: F1 — Merger with an Eli Lilly subsidiary effective 9/11/2026. F2 — At the Effective Time, outstanding options were cancelled and converted into (A) a cash amount equal to (# shares × ($6.75 − exercise price)) and (B) one CVR per share (each CVR can pay up to $2.50 subject to milestones), less applicable tax withholding.
- Filing timeliness: The Form 4 shows the transaction date as 9/11/2026; the filing does not indicate a late filing.
Context
- These were derivative dispositions tied to the corporate merger (not routine open-market sales). The insider received merger consideration per the agreement — part cash (formula-based) and part contingent value rights — rather than proceeds shown as a traditional sale price on the Form 4.
- For retail investors: this type of filing documents how insider option positions were settled in the transaction; it does not by itself indicate the insider’s personal view of the company’s future performance.